Compare · ICUI vs MDLN
ICUI vs MDLN
Side-by-side comparison of ICU Medical Inc. (ICUI) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ICUI and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $44.15B, about 12.9x ICUI ($3.41B).
- MDLN has been more active in the news (20 items in the past 4 weeks vs 4 for ICUI).
- MDLN has more recent analyst coverage (25 ratings vs 14 for ICUI).
- Company
- ICU Medical Inc.
- Medline Inc.
- Price
- $136.45+1.07%
- $33.60-2.50%
- Market cap
- $3.41B
- $44.15B
- 1M return
- +14.03%
- -
- 1Y return
- +0.20%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1992
- 2025
- News (4w)
- 4
- 20
- Recent ratings
- 14
- 25
ICU Medical Inc.
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation, such as sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. Further, it provides critical care products comprising Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
Latest ICUI
- SEC Form SD filed by ICU Medical Inc.
- ICU Medical upgraded by Needham with a new price target
- President Woolson Daniel sold $280,685 worth of shares (2,123 units at $132.21), decreasing direct ownership by 9% to 22,479 units (SEC Form 4)
- ICU Medical Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- VP, General Counsel Sanzone Virginia Ruth sold $303,624 worth of shares (2,447 units at $124.08), decreasing direct ownership by 11% to 19,460 units (SEC Form 4)
- Director Kennedy Kolleen T converted options into 1,254 shares, increasing direct ownership by 38% to 4,539 units (SEC Form 4)
- Director Hernandez Laurie converted options into 1,254 shares, increasing direct ownership by 35% to 4,862 units (SEC Form 4)
- Director Finney Elisha W converted options into 1,254 shares, increasing direct ownership by 31% to 5,249 units (SEC Form 4)
- Director Abbey Donald converted options into 1,254 shares, increasing direct ownership by 26% to 6,004 units (SEC Form 4)
- Director Hoffmeister David F converted options into 1,254 shares, increasing direct ownership by 26% to 6,004 units (SEC Form 4)
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)
- Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)
- Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Medline's Prime Vendor model expands outside the United States
- Medline Inc. announces closing of upsized secondary offering of Class A common stock
- Medline announces participation in upcoming investor conferences
- MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)